HK1056557A1 - Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative - Google Patents

Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative

Info

Publication number
HK1056557A1
HK1056557A1 HK03108847A HK03108847A HK1056557A1 HK 1056557 A1 HK1056557 A1 HK 1056557A1 HK 03108847 A HK03108847 A HK 03108847A HK 03108847 A HK03108847 A HK 03108847A HK 1056557 A1 HK1056557 A1 HK 1056557A1
Authority
HK
Hong Kong
Prior art keywords
sub
sup
coxr
preparation
transesterification process
Prior art date
Application number
HK03108847A
Other languages
English (en)
Inventor
Hugo Scheer
Nina Kammhuber
Avigdor Scherz
Alexander Brandis
Yoram Salomon
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of HK1056557A1 publication Critical patent/HK1056557A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
HK03108847A 1999-12-01 2003-12-04 Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative HK1056557A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13325399A IL133253A0 (en) 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
PCT/IL2000/000811 WO2001040232A1 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, and their preparation

Publications (1)

Publication Number Publication Date
HK1056557A1 true HK1056557A1 (en) 2004-02-20

Family

ID=11073554

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108847A HK1056557A1 (en) 1999-12-01 2003-12-04 Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative

Country Status (19)

Country Link
US (1) US7169753B2 (xx)
EP (1) EP1246826B1 (xx)
JP (1) JP2003515538A (xx)
CN (1) CN1222526C (xx)
AT (1) ATE308545T1 (xx)
AU (1) AU777761B2 (xx)
BR (1) BR0016051A (xx)
CA (1) CA2392989A1 (xx)
DE (1) DE60023748T2 (xx)
DK (1) DK1246826T3 (xx)
ES (1) ES2250214T3 (xx)
HK (1) HK1056557A1 (xx)
HU (1) HU224553B1 (xx)
IL (1) IL133253A0 (xx)
MX (1) MXPA02005455A (xx)
NO (1) NO323208B1 (xx)
PL (1) PL356391A1 (xx)
RU (1) RU2250905C2 (xx)
WO (1) WO2001040232A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
WO2002013820A1 (en) * 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
AU2003230164B2 (en) 2002-05-08 2008-05-01 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CN101247768A (zh) 2003-07-31 2008-08-20 莱特生物科学有限公司 用于光动力学治疗烧伤、创伤和相关皮肤病的系统和方法
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
ZA200700169B (en) * 2004-06-07 2008-05-28 Yeda Res & Dev Cationic bacteriochlorophyll derivatives and uses thereof
NZ551636A (en) 2004-06-09 2009-12-24 Quadra Logic Tech Inc Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
FR2924021B1 (fr) * 2007-11-27 2010-08-13 Du Vernet Michele Eymard Composition pour le traitement de la peau par therapie photodynamique
WO2009095912A1 (en) * 2008-01-28 2009-08-06 Yeda Research And Development Co. Ltd Endoscopic imaging photodynamic therapy system and methods of use
BRPI0907791A2 (pt) 2008-02-27 2015-08-04 Yeda Res & Dev Conjugados rgd-(bacterio)clorofila para terapia fotodinâmica e formação de imagem de tumores necróticos
EP2663285A2 (en) 2011-01-13 2013-11-20 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
IN2014CN02153A (xx) * 2011-08-23 2015-05-29 Yeda Res & Dev
WO2014011875A1 (en) 2012-07-11 2014-01-16 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
US10117942B2 (en) 2013-07-12 2018-11-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery
JP2019510807A (ja) * 2016-04-10 2019-04-18 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド バクテリオクロロフィル誘導体を含む、がんの治療のための併用療法
CN108341827A (zh) * 2018-02-02 2018-07-31 浙江海正药业股份有限公司 一种制备脱镁细菌叶绿素a及脱镁细菌叶绿素a酯的方法
CN108191877A (zh) * 2018-02-05 2018-06-22 云南瑞宝生物科技股份有限公司 一种从蚕沙中提取和纯化叶绿素的方法
CN111171030B (zh) * 2018-11-12 2022-11-22 浙江海正药业股份有限公司 细菌叶绿素衍生物及其制备方法
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121867A1 (de) 1991-07-02 1993-01-07 Leifeld & Lemke Maschf Vorrichtung zur pruefung der dichtigkeit von mit deckeln luftdicht verschlossenen bechern
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
EP1246826A1 (en) 2002-10-09
CN1222526C (zh) 2005-10-12
AU1729201A (en) 2001-06-12
HUP0204167A3 (en) 2004-08-30
NO323208B1 (no) 2007-01-22
NO20022599D0 (no) 2002-05-31
US20030148926A1 (en) 2003-08-07
BR0016051A (pt) 2002-07-23
ATE308545T1 (de) 2005-11-15
DE60023748D1 (de) 2005-12-08
AU777761B2 (en) 2004-10-28
PL356391A1 (en) 2004-06-28
DE60023748T2 (de) 2006-08-03
HUP0204167A2 (hu) 2003-03-28
CA2392989A1 (en) 2001-06-07
WO2001040232A1 (en) 2001-06-07
HU224553B1 (hu) 2005-10-28
IL133253A0 (en) 2001-04-30
US7169753B2 (en) 2007-01-30
ES2250214T3 (es) 2006-04-16
CN1425015A (zh) 2003-06-18
JP2003515538A (ja) 2003-05-07
RU2250905C2 (ru) 2005-04-27
MXPA02005455A (es) 2002-11-29
EP1246826B1 (en) 2005-11-02
DK1246826T3 (da) 2006-01-02
NO20022599L (no) 2002-07-11
WO2001040232A9 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
HK1056557A1 (en) Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative
DE69835438T2 (de) Photo-empfindlichkeit-erhöhende konjugate zur targeting von pathogene
CA2276180A1 (en) Method for activating human antigen-presenting cells, activated human antigen-presenting cells, and use thereof
WO2000040269A3 (en) Pharmaceutical compositions for treatment of diseased tissues
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
EP1342476A3 (en) FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
CA2131168A1 (en) Decontaminating blood components
IL137581A (en) Pharmaceutical compositions comprising keratinocyte growth factor products and a non-aqueous carrier
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
CA2169173A1 (en) Methods for stimulating erythropoiesis using thrombopoietin
Cowled et al. Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light
RU94046426A (ru) Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении
AU6721998A (en) Therapeutic use of the smr1 protein and active derivatives thereof
TR200001147T2 (tr) Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı
WO1994006449A3 (en) Morphogen-induced liver regeneration
CA2449856A1 (en) Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
CA2392168A1 (fr) Analogues de la vitamine d
WO1996015758A3 (en) Methods for stimulating erythropoiesis using thrombopoietin
PT941110E (pt) Utilizacao do factor 2 de crescimento dos ceratinocitos
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
AU5643299A (en) Humic acid and its use in the treatment of various conditions
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE ENGLISH NAME OF INVENTOR FROM ALEXANDER BRANDISH TO ALEXANDER BRANDIS

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091201